4.4 Article

Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma

Journal

JOURNAL OF ORAL PATHOLOGY & MEDICINE
Volume 42, Issue 5, Pages 374-381

Publisher

WILEY
DOI: 10.1111/jop.12026

Keywords

advanced; long-term; oral squamous cell carcinoma; prognosis; single-nucleotide polymorphisms; smoking; VEGF

Ask authors/readers for more resources

Introduction Functional polymorphisms (SNPs) of the vascular endothelial growth factor (VEGF) are associated with the incidence of oral squamous cell carcinoma (OSCC). An impact of VEGF-SNPs on prognosis of OSCC patients seems possible. Therefore, correlations between prognostic parameters of OSCC patients and five VEGF-SNPs were determined. Materials and Methods In a retrospective long-term study, in 113 OSCC patients that underwent curative resections, five VEGF-SNPs (1154G/A, +405G/C, +936 C/T, 2578 C/A, and 460 C/T) were analyzed. Associations between SNPs and prognosis (incidence of local recurrent disease, second cancer, metastases, death, total disease-free survival) were examined. Results After a mean follow-up time of 57.6months, 32 patients had local recurrences; 15 patients had second cancer, 15 patients metastases, and 23 patients died. The mean disease-free survival was 43.1months. A significant increased incidence of OSCC in smokers with the VEGF 2578 A/C and 460 C/T SNP was seen (each P<0.0001). In univariate analysis, patients with advanced OSCCs (T>2 or N>0) together with the 1154 A/A allele had a significant worse survival and a worse disease-free survival (both P<0.04). The same was seen for the +405G/G SNP (both P=0.002). In multivariate analysis, only the negative influence of the +405G/G SNP on survival in advanced OSCCs (T>2) could be confirmed (P=0.002). Discussion Possible reciprocal interactions between smoking and VEGF-SNP function were observed. Multivariate analysis confirmed the VEGF +405G/G genotype to be associated with poor survival in advanced OSCCs; a further use of this haplotype as biomarker has to be discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available